Colgate-Palmolive (CL) is currently rated a Buy by the author, who highlights its resilient fundamentals, attractive dividend yield, and sustainable Dividend King status as key strengths. Despite facing macroeconomic and geopolitical headwinds, the company posted solid first-quarter results characterized by an 8.4% growth in net...
Colgate-Palmolive Co (NYSE:CL) reported strong top and bottom line growth for its first quarter of 2026, with organic sales growth accelerating from the previous quarter driven primarily by improved volume performance in emerging markets, particularly the Asia Pacific region. The company achieved volume and pricing...
Colgate-Palmolive announced on Friday it expects approximately USD300 million in additional raw material and logistics expenses for the year due to Middle East conflict disruptions, joining rivals like Unilever and Procter & Gamble citing supply chain issues. Despite these warnings, shares rose 3 percent after...
Colgate-Palmolive Company reported its Q1 2026 earnings, with performance primarily driven by accelerated volume growth in emerging markets, particularly the Asia Pacific region, where strong global brands are leveraging scale advantages. Management attributed this broad-based growth to sustained high advertising investment and an omnichannel demand...
Colgate-Palmolive reported a strong first quarter for fiscal 2026, driven by accelerated organic sales growth and improved volumes across its global operations. This growth was primarily led by emerging markets, particularly in the Asia-Pacific region, including China and India, where management noted mid-single-digit growth in...
